Detailed TOC of Global Diagnostic Radiopharmaceuticals & Contrast Media Market Insights, Forecast to 2033
1 Study Coverage
1.1 Diagnostic Radiopharmaceuticals & Contrast Media Product Introduction
1.2 Market by Type
1.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Radiopharmaceuticals
1.2.3 Contrast Media
1.3 Market by Application
1.3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Estimates and Forecasts 2018-2033
2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region
2.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region: 2018 VS 2022 VS 2033
2.2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region (2018-2023)
2.2.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region (2024-2033)
2.2.4 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Region (2018-2033)
2.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Estimates and Forecasts 2018-2033
2.4 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region
2.4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region: 2018 VS 2022 VS 2033
2.4.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region (2018-2023)
2.4.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region (2024-2033)
2.4.4 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Region (2018-2033)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Manufacturers
3.1.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Manufacturers (2018-2023)
3.1.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Diagnostic Radiopharmaceuticals & Contrast Media in 2022
3.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Manufacturers
3.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Manufacturers (2018-2023)
3.2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Diagnostic Radiopharmaceuticals & Contrast Media Revenue in 2022
3.3 Global Key Players of Diagnostic Radiopharmaceuticals & Contrast Media, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Diagnostic Radiopharmaceuticals & Contrast Media, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Diagnostic Radiopharmaceuticals & Contrast Media, Product Offered and Application
3.8 Global Key Manufacturers of Diagnostic Radiopharmaceuticals & Contrast Media, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type
4.1.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Historical Sales by Type (2018-2023)
4.1.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Forecasted Sales by Type (2024-2033)
4.1.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2018-2033)
4.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type
4.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Historical Revenue by Type (2018-2023)
4.2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Forecasted Revenue by Type (2024-2033)
4.2.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Type (2018-2033)
4.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Type
4.3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Type (2018-2023)
4.3.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Price Forecast by Type (2024-2033)
5 Market Size by Application
5.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application
5.1.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Historical Sales by Application (2018-2023)
5.1.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Forecasted Sales by Application (2024-2033)
5.1.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2018-2033)
5.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application
5.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Historical Revenue by Application (2018-2023)
5.2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Forecasted Revenue by Application (2024-2033)
5.2.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Application (2018-2033)
5.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Application
5.3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Application (2018-2023)
5.3.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Price Forecast by Application (2024-2033)
6 US & Canada
6.1 US & Canada Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type
6.1.1 US & Canada Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2018-2033)
6.1.2 US & Canada Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2018-2033)
6.2 US & Canada Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application
6.2.1 US & Canada Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2018-2033)
6.2.2 US & Canada Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2018-2033)
6.3 US & Canada Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Country
6.3.1 US & Canada Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country: 2018 VS 2022 VS 2033
6.3.2 US & Canada Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2018-2033)
6.3.3 US & Canada Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2018-2033)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type
7.1.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2018-2033)
7.1.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2018-2033)
7.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application
7.2.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2018-2033)
7.2.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2018-2033)
7.3 Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Country
7.3.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country: 2018 VS 2022 VS 2033
7.3.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2018-2033)
7.3.3 Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2018-2033)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Diagnostic Radiopharmaceuticals & Contrast Media Market Size
8.1.1 China Diagnostic Radiopharmaceuticals & Contrast Media Sales (2018-2033)
8.1.2 China Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2018-2033)
8.2 China Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application
8.2.1 China Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2018-2033)
8.2.2 China Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type
9.1.1 Asia Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2018-2033)
9.1.2 Asia Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2018-2033)
9.2 Asia Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application
9.2.1 Asia Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2018-2033)
9.2.2 Asia Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2018-2033)
9.3 Asia Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region
9.3.1 Asia Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region: 2018 VS 2022 VS 2033
9.3.2 Asia Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region (2018-2033)
9.3.3 Asia Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region (2018-2033)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type
10.1.1 Middle East, Africa and Latin America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2018-2033)
10.1.2 Middle East, Africa and Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2018-2033)
10.2 Middle East, Africa and Latin America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application
10.2.1 Middle East, Africa and Latin America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2018-2033)
10.2.2 Middle East, Africa and Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2018-2033)
10.3 Middle East, Africa and Latin America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country
10.3.1 Middle East, Africa and Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country: 2018 VS 2022 VS 2033
10.3.2 Middle East, Africa and Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2018-2033)
10.3.3 Middle East, Africa and Latin America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2018-2033)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Amag Pharmaceuticals
11.1.1 Amag Pharmaceuticals Company Information
11.1.2 Amag Pharmaceuticals Overview
11.1.3 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Amag Pharmaceuticals Recent Developments
11.2 Bayer Healthcare
11.2.1 Bayer Healthcare Company Information
11.2.2 Bayer Healthcare Overview
11.2.3 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayer Healthcare Recent Developments
11.3 Bracco Imaging
11.3.1 Bracco Imaging Company Information
11.3.2 Bracco Imaging Overview
11.3.3 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bracco Imaging Recent Developments
11.4 Daiichi Sankyo
11.4.1 Daiichi Sankyo Company Information
11.4.2 Daiichi Sankyo Overview
11.4.3 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Daiichi Sankyo Recent Developments
11.5 GE Healthcare
11.5.1 GE Healthcare Company Information
11.5.2 GE Healthcare Overview
11.5.3 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GE Healthcare Recent Developments
11.6 Guerbet
11.6.1 Guerbet Company Information
11.6.2 Guerbet Overview
11.6.3 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Guerbet Recent Developments
11.7 Lantheus
11.7.1 Lantheus Company Information
11.7.2 Lantheus Overview
11.7.3 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Lantheus Recent Developments
11.8 Mallinckrodt
11.8.1 Mallinckrodt Company Information
11.8.2 Mallinckrodt Overview
11.8.3 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Mallinckrodt Recent Developments
11.9 Medtronic
11.9.1 Medtronic Company Information
11.9.2 Medtronic Overview
11.9.3 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Medtronic Recent Developments
11.10 Nordion
11.10.1 Nordion Company Information
11.10.2 Nordion Overview
11.10.3 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Nordion Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Diagnostic Radiopharmaceuticals & Contrast Media Industry Chain Analysis
12.2 Diagnostic Radiopharmaceuticals & Contrast Media Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Diagnostic Radiopharmaceuticals & Contrast Media Production Mode & Process
12.4 Diagnostic Radiopharmaceuticals & Contrast Media Sales and Marketing
12.4.1 Diagnostic Radiopharmaceuticals & Contrast Media Sales Channels
12.4.2 Diagnostic Radiopharmaceuticals & Contrast Media Distributors
12.5 Diagnostic Radiopharmaceuticals & Contrast Media Customers
13 Market Dynamics
13.1 Diagnostic Radiopharmaceuticals & Contrast Media Industry Trends
13.2 Diagnostic Radiopharmaceuticals & Contrast Media Market Drivers
13.3 Diagnostic Radiopharmaceuticals & Contrast Media Market Challenges
13.4 Diagnostic Radiopharmaceuticals & Contrast Media Market Restraints
14 Key Findings in The Global Diagnostic Radiopharmaceuticals & Contrast Media Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Download FREE Sample Report
